Synergistic multiple early therapy (SMET) for inflammatory diseases with pathogenic autoinflammatory feedback circuits

Affiliations

Comment

J P McFadden et al. Br J Dermatol. 2021 Aug.

. 2021 Aug;185(2):469-470.

doi: 10.1111/bjd.20077. Epub 2021 May 25.

¹ Department of Cutaneous Allergy, St John's Institute of Dermatology, King's College London, London, UK.

No abstract available

Comment on

Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Marzano AV, et al. Br J Dermatol. 2021 Jan;184(1):133-140. doi: 10.1111/bjd.18983. Epub 2020 Apr 13. Br J Dermatol. 2021. PMID: 32119111

1. Marzano AV, Genovese G, Casazza G et al. Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study. Br J Dermatol 2021; 184:133-40.
1. Cunningham L, Simmonds P, Kimber I et al. Perforin and resistance to SARS coronavirus 2. J Allergy Clin Immunol 2020; 146:52-3.
1. Mazzoni A, Salvati L, Maggi L et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest 2020; 130:4694-703.
1. Mahil SK, Dand N, Mason KJ et al. Factors associated with adverse COVID-19 outcomes in patients with psoriasis - insights from a global registry-based study. J Allergy Clin Immunol 2021; 147:60-71.
1. Varchetta S, Mele D, Oliviero B et al. Unique immunological profile in patients with COVID-19. Cell Mol Immunol 2021; 18:604-12.